These findings uncover a novel LncDARS‐AS1/ATP1A1 axis that promotes osteosarcoma metastasis through inhibition of ubiquitin‐mediated degradation and provide a rationale for repurposing digoxin in osteosarcoma therapy. This evidence concerns the gene ATP1A1 and osteosarcoma.